Treatment of Rheumatic Carditis

โ† Back to Index (

Diagnostic Findings

Modality Specific Clinical Findings
Auscultation The hallmark is a pansystolic murmur of mitral regurgitation (best heard at the apex and radiating to the axilla). A high-pitched early diastolic decrescendo murmur indicates aortic regurgitation. An apical third heart sound (S3) gallop and a soft, delayed mid-diastolic murmur (Carey Coombs' murmur) indicate increased transmitral flow across inflamed valves. A pericardial friction rub (a scratchy sound with systolic, diastolic, and presystolic components) may be present if pericarditis accompanies the carditis.
Electrocardiogram (ECG) Prolonged PR interval is a classic minor criterion but is not specifically diagnostic of carditis. Sinus tachycardia is common in the acute phase. If pericarditis is present, generalized ST-segment elevation may occur, evolving into isoelectric ST segments with T-wave inversions.
Echocardiography Essential for detecting subclinical carditis. Acute changes include annular dilation, chordal elongation (leading to anterior leaflet prolapse and lack of coaptation), and beading/nodular thickening restricted to the leaflet tips. Color Doppler confirms pathological mitral regurgitation (jet length โ‰ฅ 2 cm, peak velocity >3 m/sec, pan-systolic) or aortic regurgitation (jet length โ‰ฅ 1 cm, peak velocity >3 m/sec, pan-diastolic).
Chest Radiograph (CXR) Demonstrates cardiomegaly dependent on the severity of mitral or aortic regurgitation and left ventricular failure. Signs of pulmonary venous congestion and interstitial pulmonary edema may be present with acute decompensation.
Cardiac Catheterization Left ventriculography visually outlines the regurgitant flow of contrast into the left atrium during systole; elevated pulmonary capillary wedge pressures with prominent 'V' waves are diagnostic of significant mitral regurgitation.

Medical Management

Eradication of Group A Streptococcus (GAS)

Anti-Inflammatory (Suppressive) Therapy

Management of Congestive Heart Failure

Surgical Management

Secondary Prophylaxis

Patient Category Duration of Prophylaxis (American Heart Association Guidelines)
ARF with carditis but NO residual valvular disease For 10 years after the last ARF episode OR until age 21 years (whichever is longer).
ARF with carditis and residual heart disease (RHD) For 10 years after the last ARF episode OR until age 40 years (whichever is longer); lifelong prophylaxis may be required for severe disease or post-valve surgery.